Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trumenba immunogenicity and safety in healthy toddlers
NCT02534935Phase 2Completed
- Sponsor
- Pfizer
- Start
- Aug 2015
- Primary completion
- Aug 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 4
01
Overview
A Phase 2 trial of meningococcal group B vaccine in meningococcal disease, sponsored by Pfizer. Started Aug 2015; status: completed.
02
Drugs
meningococcal group B vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on NCT02534935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02534935.